arrow
Back
W

Walter Reinisch

Medical University of Vienna

70H-index
571Paper Count
2.9WCitation Count
Published Papers 229
Publication Date
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus
err2026-05-01
err0
PREAI
errPauline Wils; Vipul Jairath; Bruce E Sands; Axel Dignass; Fernando Magro; David T Rubin; Iris Dotan; Walter Reinisch; Parambir Dulai; Richard Gearry; Christopher Ma; Millie Long; Alessandro Armuzzi; Taku Kobayashi; Dan Turner; Sophie Vieujean; Bram Verstockt; Ailsa Hart; Silvio Danese; Laurent Peyrin-Biroulet
errShare
errSave
Unsupervised Machine Learning to Identify Distinct Response Patterns to Guselkumab in Participants With Crohn's Disease: Post Hoc Analysis of the Pooled GRAVITI and GALAXI 2/3 Studies
err2025-12-01
err0
PREAI
errDulai, Parambir S.; D'haens, Geert; Reinisch, Walter; Hart, Ailsa; Rani, Sudheer; Olurinde, Mobolaji; Van Rampelbergh, Rian; Gao, Long-Long; Yang, Zijiang; Hoops, Timothy; Valiathan, Chandni; Schreiber, Stefan
errShare
errSave
Machine Learning Models for the Assessment of the Mayo Endoscopic Score in Ulcerative Colitis Trial Endpoints: A Systematic Review
err2025-11-01
err0
PREAI
errRubin, David T.; Reinisch, Walter; Narula, Neeraj; Colucci, Daniel R.; Eastman, William; Gottlieb, Klaus; Lacerda, Ana P.; Laroux, F. Stephen; Modesto, Irene; Navajas, Emma E.; Owen, Charles C.; Wang, Yeli; Baxi, Shrujal
errShare
errSave
Serum and Histologic Eosinophilia as a Predictive Biomarker of Response to Mirikizumab in Ulcerative Colitis
err2025-11-01
err0
PREAI
errWong, Emily C. L.; Dulai, Parambir S.; Marshall, John K.; Jairath, Vipul; Reinisch, Walter; Narula, Neeraj
errShare
errSave
Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis
err2025-10-08
err0
errOAAI
errMarc Ferrante; Laurent Peyrin-Biroulet; Perttu Arkkila; Alessandro Armuzzi; Jean-Frédéric Colombel; Silvio Danese; Roberto Faggiani; Jordi Guardiola; Stephen B. Hanauer; Jorgen Jahnsen; Walter Reinisch; Xavier Roblin; Philip J. Smith; Taek Sang Kwon; Seungmin Kim; Kyoungwan Nam; Raja Atreya
errShare
errSave
A Review of the Modified Multiplier of Simple Endoscopic Score for Crohn's Disease and How to Use It in Clinical Trials and Practice
err2025-10-01
err0
PREAI
errHuan, Peter W.; Mehta, Akash; Wong, Emily C. L.; Dulai, Parambir S.; Marshall, John K.; Reinisch, Walter; Narula, Neeraj
errShare
errSave
A Post-Hoc Analysis of the VARSITY Trial Assessing Outcomes in Mild-to-Moderate Ulcerative Colitis With Histologic Activity and MES 1
err2025-10-01
err0
PREAI
errKhan, Nazmus; Wong, Emily; Narula, Neeraj; Marshall, John K.; Dulai, Parambir S.; Reinisch, Walter; Jairath, Vipul
errShare
errSave
Addition of baseline histology and fecal calprotectin does not reduce placebo rates in ulcerative colitis clinical trials: post-hoc analysis of patient-level data
err2025-10-01
err0
PREAI
errWong, Emily C. L.; Marshall, John K.; Ma, Christopher; Jairath, Vipul; Dulai, Parambir S.; Reinisch, Walter; Narula, Neeraj
errShare
errSave
Anti-TNF Therapies Promote a Proximal-to-Distal Healing Pattern in Moderate-to-Severe Ulcerative Colitis
err2025-09-01
err0
errOAAI
errWong, Emily C. L.; Dulai, Parambir S.; Marshall, John K.; Jairath, Vipul; Reinisch, Walter; Narula, Neeraj
errShare
errSave
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials
err2025-07-17
err0
PREAI
errRemo Panaccione; Brian G Feagan; Anita Afzali; David T Rubin; Walter Reinisch; Julián Panés; Silvio Danese; Tadakazu Hisamatsu; Natalie A Terry; Leonardo Salese; Rian Van Rampelbergh; Aparna Sahoo; Marion L Vetter; Jacqueline Yee; Chenglong Han; Mary Ellen Frustaci; Kitty Y Y Wan; Zijiang Yang; Jewel Johanns; Jane M Andrews; Geert R D'Haens; Bruce E Sands
errShare
errSave
Efficacy of etrasimod in ulcerative colitis: analysis of ELEVATE UC 52 and ELEVATE UC 12 by baseline endoscopic severity
err2025-07-04
err0
errOAAI
errAndres J. Yarur; Walter Reinisch; Shannon Chang; Krisztina B. Gecse; Jesse Green; Arcangelo M. Abbatemarco; Joseph Wu; Martina Goetsch; Krisztina Lazin; Gokul Pradeep; Bruce E. Sands
errShare
errSave
errShare
errSave
Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel review
err2025-07-01
err0
errOAAI
errVieujean, Sophie; Sands, Bruce E.; Panaccione, Remo; Rubin, David T.; Jairath, Vipul; Danese, Silvio; Peyrin-Biroulet, Laurent; Schreiber, Stefan; Vermeire, Severine; D'Haens, Geert; Dignass, Axel; Dulai, Parambir S.; Narula, Neeraj; Reinisch, Walter
errShare
errSave
Comparative Predictive Utility of MM-SES-CD and SES-CD for Week 52 Endoscopic Remission in the Ileum and Colon in Crohn's Disease
err2025-06-01
err0
errOAAI
errWong, Emily C. L.; Dulai, Parambir S.; Marshall, John K.; Jairath, Vipul; Reinisch, Walter; Narula, Neeraj
errShare
errSave
Validation of the Modified Multiplier of SES-CD (MM-SES-CD) to Predict Endoscopic Healing in Crohn's Disease: A Post Hoc Analysis of the SEAVUE Trial
err2025-06-01
err1
PREAI
errAhuja, Dhruv; Anvari, Sama; Wong, Emily C. L.; Dulai, Parambir; Marshall, John K.; Jairath, Vipul; Reinisch, Walter; Narula, Neeraj
errShare
errSave
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease
err2025-05-28
err0
errOAAI
errJurij Hanžel; Virginia Solitano; Sudheer Kumar Vuyyuru; Remo Panaccione; Bruce E. Sands; Laurent Peyrin-Biroulet; Silvio Danese; Geert R. D'Haens; Raja Atreya; Matthieu Allez; Charles N. Bernstein; Peter Bossuyt; Brian Bressler; Robert V. Bryant; Benjamin L. Cohen; Jean-Frederic Colombel; Ferdinando D’Amico; Axel Dignass; Marla Dubinsky; Phillip Fleshner; Richard B. Gearry; Stephen B. Hanauer; Ailsa L. Hart; Maia Kayal; Torsten Kucharzik; Peter L. Lakatos; Edouard Louis; Fernando Magro; Neeraj Narula; Rupert W. Leong; Julián Panés; Tim Raine; Zhihua Ran; Miguel D. Regueiro; Walter Reinisch; Siddharth Singh; A. Hillary Steinhart; Simon Travis; Ryan C. Ungaro; C. Janneke van der Woude; Takayuki Yamamoto; Vineet Ahuja; David T. Rubin; Parambir S. Dulai; Linda J. Cornfield; Malcolm Hogan; William J. Sandborn; Brian G. Feagan; Vipul Jairath; Christopher Ma
errShare
errSave
Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis
err2025-04-01
err0
PREAI
errReinisch, Walter; Loftus Jr, Edward, V; Schreiber, Stefan; Rubin, David T.; Louis, Edouard; Hecht, Patrick M.; Barrachina, Elena Marced; Kalabic, Jasmina; Vladea, Ramona; Sharma, Dolly; Duan, Weijiang Rachel; Zhang, Yafei; Panaccione, Remo
errShare
errSave
Application of a machine learning model in the 2+1 central reading paradigm to assess endoscopic severity in ulcerative colitis trials
err2025-01-22
err0
PREAI
errBattioui, C.; Brodskiy, P.; Gottlieb, K.; Haft-Javaherian, M.; Eastman, W.; Lehrer, J.; Yu, E.; Onken, D.; Thomason, D.; Colucci, D.; Reinisch, W.; Baxi, S.
errShare
errSave
Real-world effectiveness and safety of filgotinib with and without concomitant therapies in patients with Ulcerative Colitis: an interim analysis of the prospective, observational GALOCEAN study
err2025-01-22
err0
PREAI
errHoivik, M.; Vermeire, S.; Reinisch, W.; Seenan, J. P.; Lowenberg, M.; Schreiber, S.; Armuzzi, A.; Ricart, E.; Doherty, G.; Saldana, R.; Sawyer, W.; Rudolph, C.; Jus, A.; Joseph, C. Gilletta de Saint
errShare
errSave